BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (Amex: DDD) announced today that its contract manufacturing partner, Cardinal Healthcare, has produced batches of SCOLR’s 12 hour CDT-based pseudoephedrine tablets needed for the completion of its Abbreviated New Drug Application (ANDA) scheduled for submission later this year.
